4.6 Article

Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

How antimalarial drug resistance affects post-treatment prophylaxis

Nicholas J. White

MALARIA JOURNAL (2008)

Article Multidisciplinary Sciences

Benefits of using multiple first-line therapies against malaria

Maciej F. Boni et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Public, Environmental & Occupational Health

Efficacy and safety of dihydroartemisinin-piperaquine

H. Y. Myint et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2007)

Article Public, Environmental & Occupational Health

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children

Corine Karema et al.

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)

Article Medicine, General & Internal

Reporting of noninferiority and equivalence randomized trials - An extension of the CONSORT Statement

G Piaggio et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Microbiology

Effects of a high-fat meal on the relative oral bioavailability of piperaquine

IK Sim et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Review Microbiology

History, dynamics, and public health importance of malaria parasite resistance

AO Talisuna et al.

CLINICAL MICROBIOLOGY REVIEWS (2004)

Article Microbiology

Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria

F Ezzet et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)